< Previous Photo | Next Photo >
Guided missle mock-ups by the Raytheon Company are displayed at the 2007 Air and Space Conference and Technology Exposition and Global Air Chiefs Conference in Washington, D.C., in September.
TIM SLOAN/AFP/Getty Images
Nov 30th 2007 4:49PM
< Previous Photo | Next Photo >
| # | Blogger | Posts | Cmts |
|---|---|---|---|
| 1 | Douglas McIntyre | 100 | 0 |
| 2 | Joseph Lazzaro | 99 | 0 |
| 3 | Peter Cohan | 86 | 0 |
| 4 | Steven Mallas | 51 | 0 |
| 5 | Zac Bissonnette | 49 | 0 |
| 6 | Melly Alazraki | 48 | 0 |
| 7 | Brian White | 43 | 1 |
| 8 | Steven Halpern | 35 | 0 |
| 9 | Tom Taulli | 31 | 0 |
| 10 | Jamie Dlugosch | 24 | 0 |
| 11 | Brent Archer | 23 | 0 |
| 12 | Paul Foster | 23 | 0 |
| 13 | Jonathan Berr | 22 | 0 |
| 14 | Jim Cramer | 22 | 0 |
| 15 | Sheldon Liber | 21 | 0 |
| 16 | Sarah Gilbert | 20 | 0 |
| 17 | Trey Thoelcke | 20 | 0 |
| 18 | Jon Ogg | 20 | 0 |
| 19 | Eric Buscemi | 17 | 0 |
| 20 | Allan Halprin | 15 | 0 |
| Indexes | Change | Price |
|---|
HPQ MCD aapl SNE C wb gdp Paulson aig GeneralMotors GOOG dollar bailout Ford MSFT Google earnings china F WarrenBuffett gs Apple GE WM WMT BA economy oil McCain YHOO LEH foreclosures banks dell options GM Obama inthenews bac mer Wal-Mart thestockadvisors.com FNM Citigroup JimCramer MS featured CC wfc rimm
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
More on AOL: Money, Investing, Bonds, Broker Center, Currency, ETF Center, Futures, International Markets, Mutual Fund Center, Stock Charts, Stock Quotes, Stock Screener, Portfolios, Personal Finance, Personal Loans, Finance Calculators, Money Basics, Retirement, Taxes, Market News, Small Business
All contents copyright © 2003-2008, Weblogs, Inc. All rights reserved
BloggingStocks is a member of the Weblogs, Inc. Network. Privacy Policy, Terms of Service, Notify AOL
Other Weblogs Inc. Network blogs you might be interested in:
|
|
|
Best & Worst in Money 2008: Most shocking financial collapse
Closing Bell: Stocks slump as AMD, AT&T, GM and Merck decline
Global Q&A: A rocky road, but profits ahead
